| Assay ID | Title | Year | Journal | Article |
|---|
| AID1130793 | Antiarrhythmic activity in Swiss albino mouse assessed as protection against chloroform-induced fibrillation at 100 mg/kg, sc relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130803 | Toxicity in iv dosed coronary ligated dog assessed as concentration required to cause convulsions | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130796 | Toxicity in Swiss albino mouse assessed as induction of loss of righting reflex at 100 mg/kg, sc relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130802 | Antiarrhythmic activity in iv dosed coronary ligated dog assessed as concentration required to reduce ventricular ectopic beats to <5% of total ventricular beats measured for 5 mins | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130806 | Half life in dog | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130801 | Antiarrhythmic activity in coronary ligated dog assessed as reduction of ventricular rates at 0.5 mg/kg, iv measured for 5 mins relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130794 | Toxicity in Swiss albino mouse assessed as induction of ataxia at 100 mg/kg, sc relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130795 | Toxicity in Swiss albino mouse assessed as induction of convulsions at 100 mg/kg, sc relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130805 | Toxicity in iv dosed coronary ligated dog assessed as concentration required to cause mortality measured 87 mins after end of infusion | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130797 | Antiarrhythmic activity in sc dosed Swiss albino mouse assessed as protection against chloroform-induced fibrillation relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130800 | Antiarrhythmic activity in coronary ligated dog assessed as reduction of mean arterial blood pressure at 0.5 mg/kg, iv measured for 5 mins relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130792 | Antiarrhythmic activity in coronary ligated dog assessed as reduction of ventricular ectopic beats to <5% of total ventricular beats at 0.5 mg/kg, iv measured for 5 mins relative to control | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID1130798 | Antiarrhythmic activity in sc dosed Swiss albino mouse assessed as protection against chloroform-induced fibrillation relative to lidocaine | 1979 | Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
| New antiarrhythmic agents. 1. Primary alpha-amino anilides. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |